COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,757 Articles (22,943 medRxiv, 8,814 bioRxiv)

Most recent first Previous |  Page 369: Articles 3681-3690  | Next

Plasma-based antigen persistence in the post-acute phase of SARS-CoV-2 infection
Peluso, M. J., Swank, Z. N., Goldberg, S. A., Lu, S., Dalhuisen, T., Borberg, E., Senussi, Y., Luna, M. A., Chang Song, C., Viswanathan, B., Huang, B., Anglin, K., Hoh, R., Hsue, P. Y., Durstenfeld, M. S., Spinelli, M. A., Glidden, D. V., Henrich, T. J., Kelly, J. D., Deeks, S. G., Walt, D. R., Martin, J. N.
10.1101/2023.10.24.23297114 — Posted: 2023-10-25
Fc-dependent functional activity of ChAdOx1-S and CoronaVac vaccine-induced antibodies to the SARS-CoV-2 spike protein
Harris, A. W., Kurtovic, L., Nogueira, J., Bouzas, I., Opi, H. D., Wines, B. D., Hogarth, M. P., Poumbourios, P., Drummer, H. E., Valim, C., Porto, L. C. E., Beeson, J. G.
10.1101/2023.10.25.23297503 — Posted: 2023-10-25
Viral and host factors associated with SARS-CoV-2 disease severity in Georgia, USA
Carmola, L. R., Roebling, A. D., Khosravi, D., Langsjoen, R. M., Bombin, A., Bixler, B., Reid, A., Chen, C., Wang, E., Lu, Y., Zheng, Z., Zhang, R., Nguyen, P.-V., Arthur, R. A., Fitts, E., Gulick, D. A., Higginbotham, D., Taz, A., Ahmed, A., Crumpler, J. H., Kraft, C., Lam, W. A., Babiker, A., Waggoner, J. J., Openo, K. P., Johnson, L. M., Westbrook, A., Piantadosi, A.
10.1101/2023.10.25.23297530 — Posted: 2023-10-25
Changes in sleep duration during the long-lasting COVID-19 pandemic: individual and regional disparities
Min, J., Oh, J., Lee, W.
10.1101/2023.10.25.23297531 — Posted: 2023-10-25
'We are not the virus - Experiences of racism among East & Southeast Asian heritage young people in London during the height of the COVID-19 pandemic
Gram, L., Mau, A.
10.1101/2023.10.25.23289986 — Posted: 2023-10-25
The Influence Of Covid-19 On Patient Mobilization And Injury Attributes In The ICU: A Retrospective Analysis Of A Level II Trauma Center
Navarro, Y., Huang, E., Johnson, C., Clark, F., Coppola, S., Modi, S., Warren, G. L., Call, J.
10.1101/2023.10.25.23297544 — Posted: 2023-10-25
Estimated transmission dynamics of SARS-CoV-2 variants from wastewater are robust to differential shedding
Dreifuss, D., Huisman, J. S., Rusch, J. C., Caduff, L., Ganesanandamoorthy, P., Devaux, A. J., Gan, C., Stadler, T., Kohn, T., Ort, C., Beerenwinkel, N., Julian, T. R.
10.1101/2023.10.25.23297539 — Posted: 2023-10-25
Discovery of CMX990: A Potent SARS-CoV-2 3CL Protease Inhibitor Bearing a Novel Covalent Warhead
Elshan, N. G. R. D., Wolff, K. C., Riva, L., Woods, A. K., Grabovyi, G., Wilson, K., Rahimi, A., Pedroarena, J., Ghorai, S., Gupta, A. K., Nazarian, A., Weiss, F., Liu, Y., Mazumdar, W., Song, L., Okwor, N., Malvin, J., Bakowski, M. A., Beutler, N., Kirkpatrick, M. G., Gebara-Lamb, A., Huang, E., Nguyen-Tran, V., Chi, V., Li, S., Rogers, T. F., McNamara, C. W., Chen, J. J., Joseph, S. B., Schultz, P. G., Chatterjee, A. K.
10.1101/2023.10.24.563688 — Posted: 2023-10-25
Cross-platform comparison of highly-sensitive immunoassays for inflammatory markers in a COVID-19 cohort
Abe, K., Beer, J. C., Nguyen, T., Ariyapala, I. S., Holmes, T. H., Feng, W., Zhang, B., Kuo, D., Luo, Y., Ma, X.-J., Maecker, H. T.
10.1101/2023.10.24.563866 — Posted: 2023-10-25
Simulation-Driven Design of Stabilized SARS-CoV-2 Spike S2 Immunogens
Nuqui, X., Casalino, L., Zhou, L., Shehata, M., Wang, A., Tse, A. L., Ojha, A., Kearns, F. L., Rosenfeld, M. A., Miller, E. H., Acreman, C. M., Ahn, S.-H., Chandran, K., McLellan, J. S., Amaro, R. E.
10.1101/2023.10.24.563841 — Posted: 2023-10-25

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).